Cargando…
Testosterone Therapy in Advanced Prostate Cancer
Androgen deprivation therapy is a mainstay of advanced prostate cancer (PCa) but the resulting low testosterone levels leave men susceptible to a multitude of adverse effects. These can include vasomotor symptoms, reduced sexual desire and performance, and mood changes. Testosterone therapy (TTh) in...
Autores principales: | Chedrawe, Emily, Sathe, Aditya, White, Josh, Ory, Jesse, Ramasamy, Ranjith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850445/ https://www.ncbi.nlm.nih.gov/pubmed/36684061 http://dx.doi.org/10.1089/andro.2021.0035 |
Ejemplares similares
-
Testosterone Therapy in Men with Advanced Prostate Cancer: Too Many Unknowns for Safe Use
por: Ory, Jesse, et al.
Publicado: (2021) -
Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer
por: Delgado, Jessica, et al.
Publicado: (2022) -
Testosterone replacement and prostate cancer
por: Ramasamy, Ranjith, et al.
Publicado: (2012) -
Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men
por: Kresch, Eliyahu, et al.
Publicado: (2021) -
Impact of Testosterone Therapy on Hematocrit and Polycythemia: Evaluation of Data From Two Ongoing Open-Label Randomized Single-Center Clinical Trials
por: Gonzalez, Daniel, et al.
Publicado: (2021)